| Stroke type; medication | Adjusted OR (95% CI)* | |
|---|---|---|
| Chinese v. other Canadians | South Asian v. other Canadians | |
| Ischemic | ||
| ACE inhibitor or diuretic | 0.70 (0.64-0.76) | 0.96 (0.86-1.06) |
| ACE inhibitor + diuretic | 0.63 (0.56-0.70) | 0.88 (0.78-0.99) |
| ACE inhibitor or angiotensin-receptor blocker | 0.97 (0.89-1.06) | 1.05 (0.95-1.16) |
| Any antihypertensive | 0.92 (0.83-1.02) | 1.06 (0.93-1.20) |
| Statin | 0.97 (0.88-1.07) | 1.10 (0.98-1.24) |
| Statin, ACE inhibitor or diuretic | 0.78 (0.71-0.86) | 0.96 (0.85-1.07) |
| Statin + ACE inhibitor + diuretic | 0.64 (0.55-0.74) | 1.01 (0.87-1.17) |
| Any antihypertensive or statin | 0.89 (0.80-0.99) | 0.99 (0.87-1.14) |
| Any antihypertensive + statin | 0.99 (0.91-1.09) | 1.16 (1.03-1.29) |
| Warfarin† | 0.75 (0.59-0.95) | 0.88 (0.60-1.28) |
| Primary intracerebral hemorrhagic | ||
| ACE inhibitor or diuretic | 0.69 (0.57-0.83) | 1.64 (1.20-2.24) |
| ACE inhibitor + diuretic | 0.51 (0.38-0.69) | 1.31 (0.91-1.88) |
| ACE inhibitor or angiotensin-receptor blocker | 0.79 (0.65-0.96) | 1.75 (1.28-2.40) |
| Any antihypertensive agent | 0.82 (0.67-1.01) | 1.73 (1.21-2.49) |
Note: ACE = angiotensin-converting-enzyme.
*Adjusted for income quintile, age, sex, admitting physician (family physician v. specialist), prior medication use, and history of atrial fibrillation, hypertension, diabetes, dyslipidemia, myocardial infarction or congestive heart failure.
†Among patients with atrial fibrillation.